GGrantIndex
Sort

82,697 grants matching vaccine development

Papillomavirus Virion Proteins and Vaccines

$2,104,241
John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Shaping Antiviral Immunity by the Inflammatory, Regulatory and Tissue Environment

$2,104,058
E. John Wherry · Wistar Institute · U19 · FY2009 · AI

Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity

$2,102,997
Ofer Levy · Boston Children'S Hospital · U19 · FY2021 · AI

Clinical and Data Coordinating Center (CDCC)]

$2,102,997
Ofer Levy · Boston Children'S Hospital · U19 · FY2021 · AI

Broadly Effective HCV Vaccine

$2,102,903
Mansun Law · Scripps Research Institute, The · P01 · FY2022 · AI

Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)

$2,102,684
Khuanchai Supparatpinyo · Chiang Mai University · UM1 · FY2022 · AI

Characterization of novel genes encoded ty RNA and DNA viruses

$2,102,641
Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI

Nonhuman Primate

$2,102,174
Michael K Axthelm · Beth Israel Deaconess Medical Center · U19 · FY2015 · AI

Validation of the Remote Cognitive Aging and Alzheimer’s Disease REsearch (R-CARE) Toolbox for Diverse Populations

$2,101,898
Richard B. Lipton · Albert Einstein College Of Medicine · R01 · FY2023 · AG

Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers

$2,101,502
Steven Mark Albelda · University Of Pennsylvania · P01 · FY2020 · CA

Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers

$2,101,502
Steven Mark Albelda · University Of Pennsylvania · P01 · FY2021 · CA

Development and Production of alphavirus vaccines

$2,101,428
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2014 · AI

Multiscale Analysis of Immune Responses

$2,101,312
Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Maternal and infant immunization to eliminate breast milk transmission of HIV-1

$2,101,177
Sallie R. Permar · Duke University · P01 · FY2019 · AI

Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)

$2,101,022
Khuanchai Supparatpinyo · Chiang Mai University · UM1 · FY2023 · AI

Zika virus pathophysiology during pregnancy

$2,100,487
David H Oconnor · University Of Wisconsin-Madison · P01 · FY2018 · AI

Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies

$2,100,313
Pamela J Bjorkman · California Institute Of Technology · P01 · FY2015 · AI

Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies

$2,100,311
Pamela J Bjorkman · California Institute Of Technology · P01 · FY2017 · AI

Structure-function analysis of infection- and vaccine-induced B-cell repertoires

$2,100,193
Stephen C Harrison · Boston Children'S Hospital · P01 · FY2013 · AI

Virus-induced Cell Fate Decisions in Anti-Viral Immunity

$2,100,001
Troy D Randall · University Of Alabama At Birmingham · U19 · FY2014 · AI

Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization

$2,100,000
Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2025 · AI

Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization

$2,100,000
Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2023 · AI

Immunological Memory to Covid-19

$2,100,000
Rafi Ahmed · Emory University · U19 · FY2022 · AI

Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization

$2,100,000
Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2024 · AI

Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among American Indians/Alaska Natives

$2,100,000
Laura Hammitt · Johns Hopkins University · U01 · FY2021 · IP